Migraine Newswire (Page 6)

Migraine Newswire (Page 6)

Comprehensive Real-Time News Feed for Migraine. (Page 6)

Results 101 - 120 of 1,222 in Migraine

  1. Express Scripts targets Amgen, Lilly migraine drugs in pricing shiftRead the original story w/Photo

    Apr 24, 2018 | Reuters

    The largest U.S. manager of prescription benefits is telling drugmakers that the current pricing model is broken, and taking aim at Amgen Inc, Eli Lilly and Co and other makers of new migraine medicines to try and fix it. FILE PHOTO: An Amgen sign is seen at the company's office in South San Francisco, California, U.S., October 21, 2013.

    Comment?

  2. Express Scripts Targets New Migraine Drugs to Change US Pricing DynamicRead the original story w/Photo

    Apr 24, 2018 | News Max

    The largest U.S. manager of prescription benefits is telling drugmakers that the current pricing model is broken, and taking aim at Amgen Inc and other makers of new migraine medicines to try and fix it. Express Scripts told Reuters it is pressing them to forego the usual strategy of setting a high U.S. list price, then lowering the cost for health plans through hefty rebates.

    Comment?

  3. Express Scripts targets new migraine drugs to change U.S. pricing dynamicRead the original story w/Photo

    Apr 24, 2018 | WTAQ-AM Green Bay

    FILE PHOTO: An Amgen sign is seen at the company's office in South San Francisco, California, U.S., October 21, 2013. REUTERS/Robert Galbrai LOS ANGELES - The largest U.S. manager of prescription benefits is telling drugmakers that the current pricing model is broken, and taking aim at Amgen Inc and other makers of new migraine medicines to try and fix it.

    Comment?

  4. Adam Warren goes on disabled list with right lat strainRead the original story w/Photo

    Apr 21, 2018 | Newsday

    ... that we've got to start getting and a priority." Treatment seems to be alleviating some of Brandon Drury's migraine symptoms, and the Yankees hope to make a decision soon on whether the infielder is ready to play in games, either here or in a rehab ...

    Comment?

  5. Progress in Migraine Research, Promius Announces Presentations for...Read the original story w/Photo

    Nov 15, 2017 | PR Newswire

    Promius will present 3 platform presentations, with one presentation selected for the "Best of" session, and 4 posters including data from the 2017 Migraine in America Symptoms and Treatment Study, a longitudinal survey of more than 15,000 migraine patients. , MD, Director of Montefiore Headache Center.

    Comment?

  6. AAN: Erenumab Shows Promise for Hard-to-Treat MigraineRead the original story w/Photo

    Apr 19, 2018 | Drugs.com

    For patients with episodic migraine who have failed prior preventive migraine treatments , erenumab is associated with an increase in the proportion of patients achieving a a< 50 percent reduction in mean monthly migraine days , according to a study presented at the annual meeting of the American Academy of Neurology, held from April 21 to 27 in Los Angeles. Uwe Reuter, M.D., from The CharitA -- University Medicine Berlin, and colleagues conducted a 12-week study in which 246 patients with episodic migraine who had failed two to four prior PMTs were randomly allocated to receive erenumab or placebo.

    Comment?

  7. Trial results show that the new drug can cut episodic migraine attacks by more than half.Read the original story w/Photo

    Apr 18, 2018 | Sunday Herald

    A self-injected smart drug holds out new hope for migraine sufferers who until now have had to grit their teeth and bear the pain of thunderclap headaches. Trial results show that the antibody drug erenumab can cut episodic migraine attacks by more than half in a large proportion of cases.

    Comment?

  8. When Others Fail, New Migraine Treatment May WorkRead the original story

    Apr 18, 2018 | Health News Digest

    People who have tried unsuccessfully to prevent migraine with other treatments may find relief with a drug called erenumab, according to a preliminary study released today that will be presented at the American Academy of Neurology's 70th Annual Meeting in Los Angeles, April 21 to 27, 2018. Migraine, which can be debilitating, is often very difficult to treat.

    Comment?

  9. New drug may prevent migraines, without side effectsRead the original story w/Photo

    Apr 18, 2018 | MSN Healthy Living

    People who have tried unsuccessfully to prevent migraine with other treatments may find relief with a new drug, according to a preliminary study released Tuesday. Erenumab is part of new class of drugs -fully human monoclonal antibodies - that block calcitonin gene-related peptide , a molecule that transmits migraine pain signals during an attack.

    Comment?

  10. New Drug May Treat Stubborn MigrainesRead the original story w/Photo

    Apr 18, 2018 | News Max

    The millions of Americans who suffer from migraine may have a new source of hope -- the first of a new class of drugs aimed at warding off the headaches. Erenumab works by blocking a key brain "neurotransmitter" chemical that sends out pain signals, the research team explained.

    Comment?

  11. New hope for migraine sufferers who could self-inject with smart drug, researchers sayRead the original story w/Photo

    Apr 18, 2018 | Independent.ie

    A self-injected smart drug holds out new hope for migraine sufferers who until now have had to grit their teeth and bear the pain of thunderclap headaches. A self-injected smart drug holds out new hope for migraine sufferers who until now have had to grit their teeth and bear the pain of thunderclap headaches.

    Comment?

  12. New drug for migraine in the pipelineRead the original story w/Photo

    Apr 18, 2018 | Medical News

    According to a pilot study results released yesterday , a new drug may help provide relief to people with migraine that is unsuccessfully treated with the currently available drugs. Researchers have developed Erenumab, which belongs to a human monoclonal antibody class of drugs that can block calcitonin gene-related peptide .

    Comment?

  13. Migraine: New drug works when others fail, researchers sayRead the original story w/Photo

    Apr 17, 2018 | Newsday

    A new migraine medication - one of the first bespoke drugs for decades - appears to work well even when others have failed, researchers have said . Erenumab is a monthly injection that might soon be offered to patients on the NHS if the cost can be justified.

    Comment?

  14. Global Migraine Market: Industry Analysis & Outlook (2017-2021) : Now Available at Researchmoz.usRead the original story w/Photo

    Apr 16, 2018 | SBWire

    Migraine is a chronic neurovascular disorder characterized by severe recurrent headaches. It is one of the most common and most prevalent disabling neurological conditions, characterized by episodes often called migraine attacks.

    Comment?

  15. Investment Analysts' Weekly Ratings Changes for IntelGenx TechnologiesRead the original story w/Photo

    Apr 16, 2018 | AmericanBankingNews.com

    According to Zacks, "IntelGenx is a drug delivery company focused on the development of oral controlled-release products as well as novel rapidly disintegrating delivery systems. The Company uses its unique multiple layer delivery system to provide zero-order release of active drugs in the gastro-intestinal tract.

    Comment?

  16. Loss of vision, vomiting and unbearable pain - This is what a migraine really feels likeRead the original story w/Photo

    Apr 13, 2018 | Metro

    Yes, a headache is often one of the symptoms of migraine, and yes, I've had some really rotten headaches, but the two aren't interchangeable. I've had some awful ice-pick-in-your-eye headaches in my time, but they are a walk in the park compared to migraines.

    Comment?

  17. Migraine Drug Market By Treatment, By Therapeutic ClassRead the original story

    Apr 13, 2018 | Emailwire.com

    There are two kinds of medications used to treat migraine. Some are used to cure migraine and some are used to prevent migrane.

    Comment?

  18. Is the stress of modern life giving children migraines?Read the original story w/Photo

    Apr 11, 2018 | Daily Mail

    ... symptoms weren't affecting Sophie, rather her five-year-old son, Joshua. Indeed, her little boy first experienced a migraine just before his third birthday. As time went on, they increased in severity and as Joshua felt the headaches coming he would ...

    Comment?

  19. Global Migraine Drugs Market: Industry Demand, Usage, Application,...Read the original story w/Photo

    Apr 9, 2018 | SBWire

    Global Migraine Drugs Market is expected to reach USD 3.71 billion by 2025, from USD 2.82 billion in 2017 growing at a CAGR of 3.5% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic years2015 and 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

    Comment?

  20. IntelGenx Technologies (IGXT) Downgraded to "Strong Sell" at Zacks Investment ResearchRead the original story w/Photo

    Apr 8, 2018 | IntersportsWire

    According to Zacks, "IntelGenx is a drug delivery company focused on the development of oral controlled-release products as well as novel rapidly disintegrating delivery systems. The Company uses its unique multiple layer delivery system to provide zero-order release of active drugs in the gastro-intestinal tract.

    Comment?